DC Vaccination for Postremission Therapy in AML

NCT01734304 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

13

Enrollment

OTHER

Sponsor class

Conditions

Acute Myeloid Leukemia

Interventions

BIOLOGICAL: DC vaccination for postremission therapy in AML

Sponsor

Ludwig-Maximilians - University of Munich